cinnamic anhydride: RN given refers to cpd without isomeric designation
ID Source | ID |
---|---|
PubMed CID | 5463289 |
SCHEMBL ID | 9247555 |
MeSH ID | M0099177 |
Synonym |
---|
2-propenoic acid, 3-phenyl-, anhydride |
cinnamic acid anhydride |
cinnamic anhydride |
538-56-7 |
[(e)-3-phenylprop-2-enoyl] (e)-3-phenylprop-2-enoate |
(e)-3-phenyl-acrylic acid [(e)-3-phenyl-acryloyl] ester |
nsc 78945 |
ai3-18175 |
einecs 208-695-4 |
AKOS015994929 |
21947-71-7 |
2vmi2e65wo , |
cinnamic anhydride, (e,e)- |
(e)-cinnamic anhydride |
2-propenoic acid, 3-phenyl-, 1,1'-anhydride, (2e,2'e)- |
unii-2vmi2e65wo |
cinnamic acid anhydride [mi] |
2-propenoic acid, 3-phenyl-, anhydride, (2e,2'e)- |
3-phenylacrylic anhydride |
SCHEMBL9247555 |
J-520050 |
zimtsaureanhydrid |
trans-cinnamic anhydride |
BS-46249 |
Q27255657 |
3-phenyl-2-propenoic acid, anhydride |
(2e)-3-phenylprop-2-enoyl (2e)-3-phenylprop-2-enoate |
bis(trans-cinnamic acid)anhydride |
Excerpt | Reference | Relevance |
---|---|---|
"Cinnamic anhydrides have been shown to be more than reactive reagents, but they also act as inhibitors of the enzyme acetylcholinesterease (AChE). " | ( Substituted cinnamic anhydrides act as selective inhibitors of acetylcholinesterase. Csuk, R; Gießel, JM; Loesche, A; Serbian, I, 2019) | 2.34 |
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 3 (60.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (40.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.
| This Compound (21.83) All Compounds (24.57) |
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |